1:Khoi PN, Li S, Thuan UT, Sah DK, Kang TW, Nguyen TT, Lian S,Xia Y, Jung YD. Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells. Int J Mol Sci. 2020 Jan 1;21(1):304. doi: 10.3390/ijms21010304.

2: Li J, Narayanan K,Zhang Y, Hill RC, He F, Hansen KC, Pei M. Role of lineage-specific matrix in stem cell chondrogenesis. Biomaterials. 2020 Feb;231:119681. doi: 10.1016/j.biomaterials.2019.119681.

3:Yang R, Li X, Wu Y, Zhang G, Liu X, Li Y, Bao Y, Yang W, Cui H. EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma. Oncogene. 2020 Apr;39(14):2975-2986. doi:10.1038/s41388-020-1199-2.

4:Yang R, Wang M, Zhang G, Bao Y, Wu Y, Li X, Yang W, Cui H. E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression. Br J Cancer. 2020 Oct;123(9):1445-1455. doi: 10.1038/s41416-020-01032-y.

5:Lian FM, Yang X, Jiang YL, Yang F, Li C, Yang W, Qian C. New structural insights into the recognition of undamaged splayed-arm DNA with a single pair of non-complementary nucleotides by human nucleotide excision repair protein XPA. Int J Biol Macromol. 2020 Apr 1;148:466-474. doi: 10.1016/j.ijbiomac.2020.01.169.

6: Dengbin QI, Wei W,Ying Z, Tao Z. MiR-99b regulates cerebral ischemia neuronal injury through targeting IGF1R. Panminerva Med. 2020 Apr 28. doi: 10.23736/S0031-0808.20.03920-8.

7: Dang Z, Li L, Kong X, Zhang G, Liu Q,Li H, Li L, Zhang R, Cui W, Wang Y. Evaluation of allelic alterations in short tandem repeats in papillary thyroid cancer. Mol Genet Genomic Med. 2020 Apr;8(4):e1164. doi: 10.1002/mgg3.1164.

8:Li Y, Liang R, Sun M, Li Z, Sheng H, Wang J, Xu P, Liu S, Yang W, Lu B, Zhang S, Shan C. AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation. Cancer Lett. 2020 May 28;478:82-92. doi: 10.1016/j.canlet.2020.03.007.

9: Zhao R, Gao Q,Wang S, Yang X, Hao L. The effect of maternal seafood consumption on perinatal outcomes: a systematic review and dose-response meta-analysis. Crit Rev Food Sci Nutr. 2020 Aug 4:1-14. doi:10.1080/10408398.2020.1802573.

10: Tang M, Wang R, Feng P, Dong Q, Chen W, Zhao Y, Li A,Li H, Chen J, Huang W. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats. J Cardiovasc Pharmacol. 2020 Sep;76(3):337-348. doi: 10.1097/FJC.0000000000000862.

11: Liang Y, Ke X, Xiao Z,Zhang Y, Chen Y, Li Y, Wang Z, Lin L, Yao P, Lu J. Untargeted Metabolomic Profiling Using UHPLC-QTOF/MS Reveals Metabolic Alterations Associated with Autism. Biomed Res Int. 2020 Sep 11;2020:6105608. doi: 10.1155/2020/6105608.

12:Lian FM, Jiang YL, Yang W, Yang X. Crystal structure of sulfonic peroxiredoxin Ahp1 in complex with thioredoxin Trx2 mimics a conformational intermediate during the catalytic cycle. Int J Biol Macromol. 2020 Oct 15;161:1055-1060. doi: 10.1016/j.ijbiomac.2020.06.065.

13:Gao Y, Zhang R, Dai S, Zhang X, Li X,Bai C. Corrigendum: Role of TGF-β/Smad Pathway in the Transcription of Pancreas-Specific Genes During Beta Cell Differentiation. Front Cell Dev Biol. 2020 Nov 6;8:614840. doi: 10.3389/fcell.2020.614840.

14: Wei W, Li H, Zhang G,Zhang Y, Wu K, Bao R, Wang G, Zheng H, Xia Y, Li C. Proteasome inhibitors attenuates mitoxantrone-triggered immunogenic cell death in prostate cancer cells. Med Oncol. 2020 Nov 19;37(12):116. doi: 10.1007/s12032-020-01445-y.

15: Wei W,Li H, Zhang G, Zhang Y, Wu K, Bao R, Wang G, Zheng H, Xia Y, Li C. Proteasome inhibitors attenuates mitoxantrone-triggered immunogenic cell death in prostate cancer cells. Med Oncol. 2020 Nov 19;37(12):116. doi: 10.1007/s12032-020-01445-y.

16:Xia Y, Liu S, Li C, Ai Z, Shen W, Ren W, Yang X. Discovery of a novel ferroptosis inducer-talaroconvolutin A-killing colorectal cancer cells in vitro and in vivo. Cell Death Dis. 2020 Nov 17;11(11):988. doi: 10.1038/s41419-020-03194-2.

17: Wei W, Li H, Zhang G, Zhang Y, Wu K, Bao R, Wang G, Zheng H,Xia Y, Li C. Proteasome inhibitors attenuates mitoxantrone-triggered immunogenic cell death in prostate cancer cells. Med Oncol. 2020 Nov 19;37(12):116. doi: 10.1007/s12032-020-01445-y.

18: Li C, Sun H, Wei W, Liu Q, Wang Y,Zhang Y, Lian F, Liu F, Li C, Ying K, Huo H, Qi Z, Li B. Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression. Cell Oncol (Dordr). 2020 Dec;43(6):1099-1116. doi: 10.1007/s13402-020-00544-2.